Chimeric Advances AML Trial to New Cohort

Chimeric Therapeutics Ltd. (AU:CHM) has released an update. Chimeric Therapeutics announced the progression of its Phase 1B ADVENT-AML clinical tri...

Related Keywords

,Chimeric Therapeutics Ltd ,Chimeric Therapeutics ,